Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat ...

The proposed pertuzumab biosimilar QL1209 demonstrated equivalent efficacy and safety to reference pertuzumab (Perjeta) in ...

SHANGHAI, China I 04, 2024 I Shanghai Henlius Biotech, Inc. (2696.HK) announced that the new drug application (NDA) has been accepted by the National ...

Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update. Shanghai Henlius Biotech, Inc. has achieved a significant milestone with ...

Raleigh: Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of ...

Roche claims that Zydus' drug Sigrima, an injection used to treat breast cancer, is biologically similar to that its Perjeta/Pertuzumab. During the pendency of Zydus's appeal against the HC's October ...

Hoffmann-La Roche AG, a Swiss multinational pharmaceutical giant. The Swiss company had raised a contention that Zydus' Sigrima was biosimilar to Hoffman's Pertuzumab. The multinational drugmaker said ...

Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European Commission (EC) has approved OPUVIZ™ 40 mg/mL solution for injection in a vial, a biosimilar referencing Eylea 1,2 (aflibercept), ...

The legal battle involving Sigrima, Zydus Lifesciences’ biosimilar version of Roche’s breast cancer drug Pertuzumab, has taken a fresh turn, and this could affect further generic competition ...

The case centers around a patent infringement suit filed by the Swiss against Zydus, taking objection to the production of 'Sigrima' . It alleged that the product was a biosimilar of the original ...

Biologics are a class of drugs used to treat various diseases to help improve outcomes. Understanding the options can help you work with your doctor to make informed treatment decisions. Most of ...

Barbara O’Brien, MD, discussed findings and implications from the phase 2 TBCRC049 study evaluating the combination of tucatinib, trastuzumab, and capecitabine in HER2-positive breast cancer with ...